Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 194

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies

Open access
Xie, Yuan-Hong, Gao, Qin-Yan, Cai, Guo-Xiang, Sun, Xiao-Ming, Zou, Tian-Hui, Chen, Hui-Min, Yu, Si-Yi, Qiu, Yi-Wen, Gu, Wei-Qi, Chen, Xiao-Yu, Cui, Yun, Sun, Danfeng, Liu, Zhan-Ju, Cai, San-Jun, Xu, Jie, Chen, Ying-Xuan, Fang, Jing-Yuan·2017·EBioMedicine

Abstract

OBJECTIVE: Current non-invasive early detection of colorectal cancer (CRC) requires improvement. We aimed to identified a fecal Clostridium symbiosum-based biomarker for early and advanced colorectal cancer detection. DESIGN: In the test stage, the relative abundance of Clostridium symbiosum (C. symbiosum) was measured by qPCR in 781 cases including 242 controls, 212 colorectal adenoma (CRA) patients, 109 early CRC (tumor restricted to the submucosa) patients, 218 advanced CRC patients. The prediction accuracy was compared to Fusobacterium nucleatum (F. nucleatum), fecal immunochemical test (FIT) and CEA (carcinoembryonic antigen) and validated in an independent cohort of 256 subjects. Current status of the trial:ongoing/still enrolling. Primary endpoint:June, 2017 (Clinicaltrials.gov Identifier NCT02845973). RESULTS: Significant stepwise increase of C. symbiosum abundance was found in CRA, early CRC and advanced CRC (P<0.01). C. symbiosum outperformed all the other markers in early CRC prediction performance. The combination of C. symbiosum and FIT achieved better performance (0.803 for test cohort and 0.707 for validation cohort). For overall discrimination of CRCs, the combination of all above markers achieved the performance of 0.876. CONCLUSIONS: Fecal C. symbiosum is a promising biomarker for early and noninvasive detection of colorectal cancer, being more effective than F. nucleatum, FIT and CEA. Combining C. symbiosum and FIT or CEA may improve the diagnosis power.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ebiom.2017.10.005

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 194

Metadata

Authors
Xie, Y.-H., Gao, Q.-Y., Cai, G.-X., Sun, X.-M., Zou, T.-H., Chen, H.-M., Yu, S.-Y., Qiu, Y.-W., Gu, W.-Q., Chen, X.-Y., Cui, Y., Sun, D., Liu, Z.-J., Cai, S.-J., Xu, J., Chen, Y.-X., & Fang, J.-Y.
Venue
EBioMedicine
Publisher
Elsevier BV
Published
2017-11
Volume
25
Pages
32-40
ISSN
2352-3964 (ISSN-L)
OpenAlex
W2762762439
Cited by
194
References
12
FWCI
4.63
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies. https://app.cochat.ai/papers/10.1016/j.ebiom.2017.10.005
The paper
Xie, Y.-H., Gao, Q.-Y., Cai, G.-X., Sun, X.-M., Zou, T.-H., Chen, H.-M., Yu, S.-Y., Qiu, Y.-W., Gu, W.-Q., Chen, X.-Y., Cui, Y., Sun, D., Liu, Z.-J., Cai, S.-J., Xu, J., Chen, Y.-X., & Fang, J.-Y. (2017). Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies. EBioMedicine. https://doi.org/10.1016/j.ebiom.2017.10.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.